Lv1
60 积分 2024-10-17 加入
Risk of tuberculosis is higher with anti–tumor necrosis factor monoclonal antibody therapy than with soluble tumor necrosis factor receptor therapy: The three‐year prospective french research axed on tolerance of biotherapies registry
29天前
已完结
重组人Ⅱ型肿瘤坏死因子受体-抗体融合蛋白治疗强直性脊柱炎的多中心双盲随机对照临床研究
29天前
已关闭
依那西普治疗强直性脊柱炎的多中心、随机、双盲、安慰剂对照临床研究
29天前
已完结
The pathogenesis of psoriatic arthritis
2个月前
已完结
The Early Rheumatoid Arthritis (ERA) trial comparing the efficacy and safety of etanercept and methotrexate
2个月前
已关闭
Evaluation of proximod, a selective agonist of sphingosine-1-phosphate receptor-1, in healthy volunteers and patients with rheumatoid arthritis: a phase 1, double-blind, randomised, placebo-controlled, ascending dose trial
6个月前
已完结
Difference in the risk of serious infections in patients with rheumatoid arthritis treated with adalimumab, infliximab and etanercept: results from the Dutch Rheumatoid Arthritis Monitoring (DREAM) registry
7个月前
已关闭
Immunogenicity, adalimumab levels and clinical response in ankylosing spondylitis patients during 24 weeks of follow-up
8个月前
已完结
Bedaquiline and delamanid for drug-resistant tuberculosis: a clinician’s perspective
9个月前
已完结
Bedaquiline and delamanid for drug-resistant tuberculosis: a clinician’s perspective
9个月前
已关闭
皖公网安备34019202002308
